Skip to content

Insider · CIK 0002112339

Brian Savage

officer

Files at TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD). First filing Sep 22, 2026, latest Sep 22, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $285k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TEVA: TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVAOct 9, 2026 · close 41.10

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
32Weak
TEVAsell 2
TEVA PHARMACEUTICAL INDUSTRIES LTD
$285k
7,342 shares
-46%+113% from low-1% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 18, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
MOption exercise
Ordinary Shares
+4,503$34.70$156k15,84220 d ago
Sep 18, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SOpen-market sale
Ordinary Shares
-4,503$38.69$174k11,33920 d ago
Sep 18, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SOpen-market sale
Ordinary Shares
-2,525$39.15$99k8,81420 d ago
Sep 18, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
SOpen-market sale
Ordinary Shares
-314$38.70$12k8,50020 d ago
Sep 18, 2026TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
MOption exercise
Stock Options (right to buy)derivative
-4,503$34.70$156k020 d ago

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Brian Savage: insider trades and track record | InsiderTell